We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Thomas Heydler Appointed to the Supervisory Board of Eppendorf AG
Product News

Thomas Heydler Appointed to the Supervisory Board of Eppendorf AG

Thomas Heydler Appointed to the Supervisory Board of Eppendorf AG
Product News

Thomas Heydler Appointed to the Supervisory Board of Eppendorf AG

Thomas Heydler

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Thomas Heydler Appointed to the Supervisory Board of Eppendorf AG"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Thomas Heydler has been a member of the Supervisory Board of Eppendorf AG since January 25, 2019. He succeeds Dr. Michael Schroeder, who resigned for personal reasons.

"With Thomas Heydler, we have succeeded in gaining another very experienced manager for the Eppendorf Supervisory Board. We are looking forward to this and to working with him", says Philipp von Loeper, Chairman of the Supervisory Board of Eppendorf AG. "We are confident that he will enrich the work of our Supervisory Board with his many years of international experience as CEO and his outstanding entrepreneurial competence."

Thomas Heydler has been CEO of Definiens AG, Munich, Germany, a specialized software and solution provider in the pharmaceutical industry, since 2004. Previously, he was CEO and Managing Director of various software companies in Germany and the USA. Thomas Heydler has more than 30 years of entrepreneurial expertise and a deep understanding of the global software business in the pharmaceutical and life science industries.
Advertisement